Solventum

ISIN US83444M1018

 | 

WKN A407ZE

 

Overview

Description

Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.
Healthcare Healthcare Equipment Other Medical Devices United States

Financials

Key metrics

Market capitalisation, EUR 10,921.50 m
EPS, EUR 2.55
P/B ratio 4.10
P/E ratio 25.45
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 7,630.62 m
Net income, EUR 442.82 m
Profit margin 5.80%

What ETF is Solventum in?

There are 261 ETFs which contain Solventum. All of these ETFs are listed in the table below. The ETF with the largest weighting of Solventum is the First Trust US IPO Index UCITS ETF Acc.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.